ArticleMolecular and clinical oncology2026

Urinary metabolomic signatures associated with early adverse events during volumetric modulated arc therapy for prostate cancer: A secondary analysis of a public dataset.

Mai Fukushi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.